Medical Health Cluster

Vacunas

FDA Authorizes COVID Booster for Younger Kids

A third dose of Pfizer/BioNTech’s COVID-19 vaccine is authorized for kids ages 5 to 11 years, the FDA announced on Tuesday. The third 10 μg dose may be administered to children at least 5 months after the initial primary series under the terms of the emergency use authorization (EUA), the agency […]

Read More

Scientists identify characteristics to better define long COVID

A research team supported by the National Institutes of Health has identified characteristics of people with long COVID and those likely to have it. Scientists, using machine learning techniques, analyzed an unprecedented collection of electronic health records (EHRs) available for COVID-19 research to better identify who has long COVID. Exploring […]

Read More

Cytokine Patterns May Help Classify Long COVID Subsets

Patterns of inflammatory proteins in the blood of people with long COVID may someday help guide individualized treatment, new findings suggest. Researchers studied 55 people with long COVID who had been only mildly ill with COVID-19 and found that roughly two-thirds had high levels of inflammatory proteins in their blood, […]

Read More

COVID-19: el resumen semanal (6 al 12 de mayo de 2022)

Organización Mundial de la Salud: por la pandemia fallecieron 15 millones de personas en 2020 y 2021 La Organización Mundial de la Salud (OMS) estimó que la pandemia de COVID-19 mató a 14,9 millones de personas de manera directa e indirecta entre enero de 2020 y diciembre de 2021, más del […]

Read More

¡ORRGULLO NACIONAL! Científicos mexicanos desarrollan tratamiento contra inflamación por COVID-19

Científicos mexicanos desarrollaron un protocolo con un medicamento que demostró ayudar a tratar el proceso inflamatorio que provoca la COVID-19. El estudio, realizado en el Instituto Nacional de Nutrición, utilizó al colágeno polivinilpirrolidona, también conocido como fibroquel, un medicamento 100 % mexicano. El medicamento es utilizado como un modulador de […]

Read More

Age Range Is Expanded for Universal Hepatitis B Vaccination

An update from the CDC’s Advisory Committee on Immunization Practices (ACIP) is intended to boost low hepatitis B vaccination rates and decrease disease cases among adults aged 19 to 59 years. James Cavallini/sciencesource.com Instead of screening this age group for vaccination based on risk factors such as injection drug use, having multiple […]

Read More

Estudio en Reino Unido vincula casos de hepatitis infantil aguda con contagios de COVID

Un nuevo estudio revela que puede existir un vínculo entre los contagios de COVID-19 y los casos de hepatitis aguda registrados en niños de distintos países del mundo en las últimas semanas. El trabajo de investigación publicado en el portal de The Lancet señala que algunos de los niños del Reino Unido e Israel […]

Read More

Breakthrough COVID Deaths Increasing in US

Breakthrough deaths are making up a larger portion of those who have died from COVID-19, according to a new analysis from ABC News. That means more COVID-19 deaths are occurring among those who are vaccinated against the coronavirus. But public health experts say that should be expected as more Americans reach full vaccination […]

Read More

Mysterious Hepatitis in Kids: What We Know and Don’t Know Now

At least 228 probable cases of severe hepatitis in children have been reported across 20 countries worldwide, according to the World Health Organization on May 4. In the United States, the Centers for Disease Control and Prevention (CDC) is investigating 109 cases of pediatric hepatitis of unknown cause, the public health agency […]

Read More